Mark Shelton

Certara (United States) — United States

Medicine · Health Sciences

27h-index5.1kcitations83works1.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

HIV/AIDS drug development and treatment(36), HIV Research and Treatment(18), Pneumocystis jirovecii pneumonia detection and treatment(16), HIV/AIDS Research and Interventions(11), Hepatitis C virus research(9)

Publications83 total

Effect of Food Intake or Coadministration With an Acid‐Reducing Agent on Lenacapavir Pharmacokinetics Following Oral Administration
Clinical Pharmacology in Drug Development·2025· 1 cited
505. Drug-drug Interaction Profiling of Obeldesivir, A Promising Oral Treatment for COVID-19
Open Forum Infectious Diseases·2023· 3 citedOpen Access
538. Clinical Evaluation of Drug-drug Interactions with Remdesivir
Open Forum Infectious Diseases·2023· 1 citedOpen Access
Effect of hepatic impairment on the pharmacokinetics of ripretinib.
Journal of Clinical Oncology·2022· 1 cited
Effects of CYP3A Inhibition, CYP3A Induction, and Gastric Acid Reduction on the Pharmacokinetics of Ripretinib, a Switch Control KIT Tyrosine Kinase Inhibitor
Clinical Pharmacology in Drug Development·2022· 9 citedOpen Access
Abstract CT132: Effect of gastric acid reduction and strong CYP3A induction/inhibition on the pharmacokinetics of ripretinib, a switch control tyrosine kinase inhibitor
Cancer Research·2021
Model‐Informed Drug Development for Anti‐Infectives: State of the Art and Future
Clinical Pharmacology & Therapeutics·2021· 69 citedOpen Access
A Neighborhood with Forest and Trees
University of Pittsburgh Press eBooks·2017
Lesley S.J. Farmer and Alan M. Safer. Library Improvement through Data Analysis. Chicago: ALA Neal-Schuman, 2016. 184p. Paper, $75.00 (ISBN 978-0-8389-1425-0). LCCN 2015046382.
College & Research Libraries·2017Open Access
<b>Lesley S.J. Farmer and Alan M. Safer.</b> <i>Library Improvement through Data Analysis</i> . Chicago: ALA Neal-Schuman, 2016. 184p. Paper, $75.00 (ISBN 978-0-8389-1425-0). LCCN 2015046382.
College & Research Libraries·2017· 1 citedOpen Access
A Randomized, Double-Blind, Placebo-Controlled Trial of Pleconaril for the Treatment of Neonates With Enterovirus Sepsis
Journal of the Pediatric Infectious Diseases Society·2015· 162 citedOpen Access
An Open-Label, Multicenter, Randomized Phase Ib/II Study of Eribulin Mesylate Administered in Combination With Pemetrexed Versus Pemetrexed Alone as Second-Line Therapy in Patients With Advanced Nonsquamous Non–Small-Cell Lung Cancer
Clinical Lung Cancer·2014· 14 cited
E7080 (lenvatinib) in addition to best supportive care (BSC) versus BSC alone in third-line or greater nonsquamous, non-small cell lung cancer (NSCLC).
Journal of Clinical Oncology·2014· 17 cited
80A Randomized, Double-Blind, Placebo-Controlled Trial of Pleconaril for the Treatment of Neonates with Enterovirus Sepsis
Open Forum Infectious Diseases·2014Open Access
Durability of sustained response shown in paediatric patients with chronic hepatitis C who were treated with interferon alfa‐2b plus ribavirin
Journal of Viral Hepatitis·2011· 13 cited
Oral Acyclovir Suppression and Neurodevelopment after Neonatal Herpes
New England Journal of Medicine·2011· 320 citedOpen Access
Zanamivir Pharmacokinetics and Pulmonary Penetration into Epithelial Lining Fluid following Intravenous or Oral Inhaled Administration to Healthy Adult Subjects
Antimicrobial Agents and Chemotherapy·2011· 31 citedOpen Access
2008 DOSE-RANGING, THREE-DAY MONOTHERAPY STUDY OF THE HCV NS3 PROTEASE INHIBITOR GS-9256
Journal of Hepatology·2010· 12 cited
Safety of Oseltamivir Compared With the Adamantanes in Children Less Than 12 Months of Age
The Pediatric Infectious Disease Journal·2010· 47 citedOpen Access
High sustained virologic response rates in children with chronic hepatitis C receiving peginterferon alfa-2b plus ribavirin
Journal of Hepatology·2010· 146 cited
page 1 of 5Next →

Frequent Co-authors

Gene D. Morse(13), Ross G. Hewitt(12), Richard J. Whitley(8), David W. Kimberlin(7), Richard F. Jacobs(7), Alain Lachaux(5), Mary Beth Wire(5), Yu Lou(5), John M. Adams(5), Pablo J. Sánchez(4), John S. Bradley(4), Gretchen A. Cloud(4), Thomas Lang(4), Alice O’Donnell(4), Chin‐Yu Lin(3), Gail J. Demmler(3), Robert F. Pass(3), Jan Kiell(3), Dwight A. Powell(3), William C. Gruber(3)